Hat mitgewirkt an:
-
Funktionelle Analyse therapeutisch relevanter molekularer Zielstrukturen bei der Signaltransduktion onkogener Tyrosinkinasen in Lymphomen und Leukämien
-
Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis
-
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
-
Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma